Are you involved in antenatal sickle cell and thalassaemia (SCT) screening? Do you counsel women and couples at risk of having a baby with a significant haemoglobin disorder? Are you aware of all the resources available to support your counselling?
We have published the annual data report for the NHS Sickle Cell and Thalassaemia (SCT) Screening Programme covering 1 April 2015 to 31 March 2016.
Over the past few months, the NHS Sickle Cell and Thalassaemia (SCT) Screening Programme has consulted widely with colleagues from a range of services, including midwifery, specialist nurses and clinicians, screening laboratories, and patient organisations to help us revise and …
In this blog article, antenatal and newborn screening coordinator Louise Frost explains how the creation of an antenatal booking centre (ABC) improved early access and continuity of care for women at Princess Royal University Hospital (PRUH) in south east London.
We’re pleased to announce the publication of an updated version of the newborn laboratory handbook for the NHS Sickle Cell and Thalassaemia (SCT) Screening Programme.
The NHS Fetal Anomaly Screening Programme (FASP) is pleased to launch a new counselling resource leaflet: ‘Chorionic villus sampling (CVS) and amniocentesis: information for parents’.
We’ve updated the antenatal and newborn screening e-learning module in line with clinical best practice and quality assurance requirements.
I was appointed antenatal and newborn screening coordinator at King’s College Hospital, London, on 1 June 2014.
I’m the study co-ordinator and statistician for the National Study of HIV in Pregnancy and Childhood (NSHPC).
In his latest PHE Screening blog post written for his fellow GPs, Dr Jim McMorran looks at primary care issues relating to sickle cell and thalassaemia (SCT) screening.